TB Diagnostics Market Size, Growth & Statistics Report 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global TB Diagnostics Market Size Analysis

Global TB Diagnostics Market Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nucleic Acid Testing (NAT)
  1. By Value
3. Skin Test / Mantoux Test (TST)
  1. By Value
4. Blood Test / Serology Test
  1. By Value
5. SMEAR Microscopy
  1. By Value
6. Cultured-Based Tests
  1. By Value
7. Radiography Tests
  1. By Value
8. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Physician’s Office Laboratories
  1. By Value
4. Reference Laboratories
  1. By Value
5. Academics and Research Facilities
  1. By Value

North America Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nucleic Acid Testing (NAT)
  1. By Value
3. Skin Test / Mantoux Test (TST)
  1. By Value
4. Blood Test / Serology Test
  1. By Value
5. SMEAR Microscopy
  1. By Value
6. Cultured-Based Tests
  1. By Value
7. Radiography Tests
  1. By Value
8. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Physician’s Office Laboratories
  1. By Value
4. Reference Laboratories
  1. By Value
5. Academics and Research Facilities
  1. By Value
U.S.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nucleic Acid Testing (NAT)
    1. By Value
  3. Skin Test / Mantoux Test (TST)
    1. By Value
  4. Blood Test / Serology Test
    1. By Value
  5. SMEAR Microscopy
    1. By Value
  6. Cultured-Based Tests
    1. By Value
  7. Radiography Tests
    1. By Value
  8. Others
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Physician’s Office Laboratories
    1. By Value
  4. Reference Laboratories
    1. By Value
  5. Academics and Research Facilities
    1. By Value
Canada

Europe Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nucleic Acid Testing (NAT)
  1. By Value
3. Skin Test / Mantoux Test (TST)
  1. By Value
4. Blood Test / Serology Test
  1. By Value
5. SMEAR Microscopy
  1. By Value
6. Cultured-Based Tests
  1. By Value
7. Radiography Tests
  1. By Value
8. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Physician’s Office Laboratories
  1. By Value
4. Reference Laboratories
  1. By Value
5. Academics and Research Facilities
  1. By Value
U.K.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nucleic Acid Testing (NAT)
    1. By Value
  3. Skin Test / Mantoux Test (TST)
    1. By Value
  4. Blood Test / Serology Test
    1. By Value
  5. SMEAR Microscopy
    1. By Value
  6. Cultured-Based Tests
    1. By Value
  7. Radiography Tests
    1. By Value
  8. Others
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Physician’s Office Laboratories
    1. By Value
  4. Reference Laboratories
    1. By Value
  5. Academics and Research Facilities
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nucleic Acid Testing (NAT)
  1. By Value
3. Skin Test / Mantoux Test (TST)
  1. By Value
4. Blood Test / Serology Test
  1. By Value
5. SMEAR Microscopy
  1. By Value
6. Cultured-Based Tests
  1. By Value
7. Radiography Tests
  1. By Value
8. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Physician’s Office Laboratories
  1. By Value
4. Reference Laboratories
  1. By Value
5. Academics and Research Facilities
  1. By Value
China
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nucleic Acid Testing (NAT)
    1. By Value
  3. Skin Test / Mantoux Test (TST)
    1. By Value
  4. Blood Test / Serology Test
    1. By Value
  5. SMEAR Microscopy
    1. By Value
  6. Cultured-Based Tests
    1. By Value
  7. Radiography Tests
    1. By Value
  8. Others
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Physician’s Office Laboratories
    1. By Value
  4. Reference Laboratories
    1. By Value
  5. Academics and Research Facilities
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nucleic Acid Testing (NAT)
  1. By Value
3. Skin Test / Mantoux Test (TST)
  1. By Value
4. Blood Test / Serology Test
  1. By Value
5. SMEAR Microscopy
  1. By Value
6. Cultured-Based Tests
  1. By Value
7. Radiography Tests
  1. By Value
8. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Physician’s Office Laboratories
  1. By Value
4. Reference Laboratories
  1. By Value
5. Academics and Research Facilities
  1. By Value
UAE
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nucleic Acid Testing (NAT)
    1. By Value
  3. Skin Test / Mantoux Test (TST)
    1. By Value
  4. Blood Test / Serology Test
    1. By Value
  5. SMEAR Microscopy
    1. By Value
  6. Cultured-Based Tests
    1. By Value
  7. Radiography Tests
    1. By Value
  8. Others
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Physician’s Office Laboratories
    1. By Value
  4. Reference Laboratories
    1. By Value
  5. Academics and Research Facilities
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nucleic Acid Testing (NAT)
  1. By Value
3. Skin Test / Mantoux Test (TST)
  1. By Value
4. Blood Test / Serology Test
  1. By Value
5. SMEAR Microscopy
  1. By Value
6. Cultured-Based Tests
  1. By Value
7. Radiography Tests
  1. By Value
8. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Physician’s Office Laboratories
  1. By Value
4. Reference Laboratories
  1. By Value
5. Academics and Research Facilities
  1. By Value
Brazil
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nucleic Acid Testing (NAT)
    1. By Value
  3. Skin Test / Mantoux Test (TST)
    1. By Value
  4. Blood Test / Serology Test
    1. By Value
  5. SMEAR Microscopy
    1. By Value
  6. Cultured-Based Tests
    1. By Value
  7. Radiography Tests
    1. By Value
  8. Others
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Physician’s Office Laboratories
    1. By Value
  4. Reference Laboratories
    1. By Value
  5. Academics and Research Facilities
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

TB Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Thermo Fisher Scientific Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Becton Dickinson and Company
Hoffmann-La Roche Ltd.
Qiagen NV
Hologic Inc.
BioMerieux SA
Oxford Immunotec Ltd.
Cepheid Inc.
Akonni Biosystems Inc.
PAR Pharmaceuticals
Alere Inc. (Abbott)
Lionex GmbH
Creative Diagnostics
Hain Life Science.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment